COMPANY PROFILE · /noetik
N
Noetik
AI company building biological foundation models trained on human tissue data for translational research. Generates multimodal data from primary human tissue samples and trains models to predict clinical outcomes in cancer and other diseases, bridging the gap between molecular data and human efficacy.
Fresh · 5d ago
Latest valuation
~$400-600M (estimated)
Annual Recurring Revenue
—
Headcount
~60-80 (estimated)
Funding total
$100M+ (estimated total Series A)
OVERVIEW
Announced multi-year collaboration with GSK (Jan 2026) to develop biological foundation models for cancer clinical outcome prediction. Focus on filling gap in human translational data vs. public protein datasets. Heavy academic/pharma validation model.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.